Wanjia Group Holdings Ltd
HKEX:401
Wanjia Group Holdings Ltd
HKEX:401
Price:
0.076 HKD
Updated:
May 10, 2024
P/E
Price to Earnings
Price to Earnings
33.4
Current
-1.6
Median
23.4
Industry
Higher
than median
Higher
than industry value
Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.
P/E
=33.4
Market Cap
/
42.6m
Net Income
1.3m
All Countries
| Market Cap | P/E | ||||
|---|---|---|---|---|---|
| HK |
|
Wanjia Group Holdings Ltd
HKEX:401
|
42.6m HKD | 33.4 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
72.7B USD | 24.3 | |
| US |
|
Cencora Inc
NYSE:COR
|
44.7B USD | 24.1 | |
| US |
|
Amerisourcebergen Corp
NYSE:ABC
|
35.4B USD | 20.9 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
23.9B USD | 43.3 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
9.5B USD | 22.8 | |
| KR |
C
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 89.6 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
64.8B HKD | 7 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
58.4B CNY | 21.6 | |
| IT |
|
Amplifon SpA
MIL:AMP
|
7.6B EUR | 49.2 | |
| CN |
S
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
51.7B CNY | 13.7 |
P/E Forward Multiples
Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/E
N/A
2-Years Forward
P/E
N/A
3-Years Forward
P/E
N/A
You don't have any saved screeners yet
